01-01-2006 | Clinical Trials Report
The PROactive study: Pioglitazone in the secondary prevention of macrovascular events in patients with type 2 diabetes
Published in: Current Diabetes Reports | Issue 1/2006
Login to get access01-01-2006 | Clinical Trials Report
Published in: Current Diabetes Reports | Issue 1/2006
Login to get access